120 related articles for article (PubMed ID: 10394721)
1. Cowpea mosaic virus-based vaccines.
Lomonossoff GP; Hamilton WD
Curr Top Microbiol Immunol; 1999; 240():177-89. PubMed ID: 10394721
[No Abstract] [Full Text] [Related]
2. The development of cowpea mosaic virus as a potential source of novel vaccines.
Porta C; Spall VE; Lin T; Johnson JE; Lomonossoff GP
Intervirology; 1996; 39(1-2):79-84. PubMed ID: 8957673
[TBL] [Abstract][Full Text] [Related]
3. [Cowpea mosaic virus chimeric particles bearing ectodomain of matrix protein 2 (M2E) of influenza A virus: production and characteristics].
Meshcheriakova IuA; El'darov MA; Migunov AI; Stepanova LA; Repko IA; Kiselev OI; Lomonosov DP; Skriabin KG
Mol Biol (Mosk); 2009; 43(4):741-50. PubMed ID: 19807038
[TBL] [Abstract][Full Text] [Related]
4. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
[TBL] [Abstract][Full Text] [Related]
5. Development of cowpea mosaic virus-based vectors for the production of vaccines in plants.
Cañizares MC; Lomonossoff GP; Nicholson L
Expert Rev Vaccines; 2005 Oct; 4(5):687-97. PubMed ID: 16221070
[TBL] [Abstract][Full Text] [Related]
6. Cowpea mosaic virus as a vaccine carrier of heterologous antigens.
Brennan FR; Jones TD; Hamilton WD
Mol Biotechnol; 2001 Jan; 17(1):15-26. PubMed ID: 11280928
[TBL] [Abstract][Full Text] [Related]
7. Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization.
Durrani Z; McInerney TL; McLain L; Jones T; Bellaby T; Brennan FR; Dimmock NJ
J Immunol Methods; 1998 Nov; 220(1-2):93-103. PubMed ID: 9839930
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide.
McInerney TL; Brennan FR; Jones TD; Dimmock NJ
Vaccine; 1999 Mar; 17(11-12):1359-68. PubMed ID: 10195771
[TBL] [Abstract][Full Text] [Related]
9. Chimeric virus-like particles as vaccines.
Krüger DH; Ulrich R; Gerlich WH
Biol Chem; 1999 Mar; 380(3):275-6. PubMed ID: 10223328
[No Abstract] [Full Text] [Related]
10. Induction of an immune response to transmissible gastroenteritis coronavirus using vectors with enteric tropism.
Smerdou C; Torres JM; Sánchez CM; Suñé C; Antón IM; Medina M; Castilla J; Graham FL; Enjuanes L
Adv Exp Med Biol; 1993; 342():455-62. PubMed ID: 7516110
[No Abstract] [Full Text] [Related]
11. Genetic Modifications of Icosahedral Plant Virus-based Nanoparticles for Vaccine and Immunotherapy Applications.
Narayanan KB; Han SS
Curr Protein Pept Sci; 2017 Aug; 18(11):1141-1151. PubMed ID: 28440187
[TBL] [Abstract][Full Text] [Related]
12. Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides.
Porta C; Spall VE; Loveland J; Johnson JE; Barker PJ; Lomonossoff GP
Virology; 1994 Aug; 202(2):949-55. PubMed ID: 8030255
[TBL] [Abstract][Full Text] [Related]
13. Potential of chimaeric plant virus particles as novel, stable vaccines.
Xu F; Jones TD; Rodgers PB
Dev Biol Stand; 1996; 87():201-5. PubMed ID: 8854018
[TBL] [Abstract][Full Text] [Related]
14. Plant expression systems for the production of vaccines.
Ma JK; Vine ND
Curr Top Microbiol Immunol; 1999; 236():275-92. PubMed ID: 9893365
[No Abstract] [Full Text] [Related]
15. [Repertoire of epitopes of human immunodeficiency virus proteins and the search for vaccines and diagnostic kits].
Kharchenko EP; Klimenko AP
Dokl Akad Nauk SSSR; 1992; 322(1):189-92. PubMed ID: 1380907
[No Abstract] [Full Text] [Related]
16. Immune response induced in mice oral immunization with cowpea severe mosaic virus.
Florindo MI; de Aragao ME; da Silva AC; Otoch ML; Melo DF; Lima JA; Lima MG
Braz J Med Biol Res; 2002 Jul; 35(7):827-35. PubMed ID: 12131924
[TBL] [Abstract][Full Text] [Related]
17. Synthetic recombinant vaccines against viral agents.
Arnon A; Levi R
Int Arch Allergy Immunol; 1995 Dec; 108(4):321-6. PubMed ID: 7580302
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the immune response to canine parvovirus induced by vaccination with chimaeric plant viruses.
Nicholas BL; Brennan FR; Martinez-Torrecuadrada JL; Casal JI; Hamilton WD; Wakelin D
Vaccine; 2002 Jun; 20(21-22):2727-34. PubMed ID: 12034099
[TBL] [Abstract][Full Text] [Related]
19. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles.
Kit S; Kit M; DiMarchi RD; Little SP; Gale C
Arch Virol; 1991; 120(1-2):1-17. PubMed ID: 1718244
[TBL] [Abstract][Full Text] [Related]
20. Influence of three-dimensional structure on the immunogenicity of a peptide expressed on the surface of a plant virus.
Taylor KM; Lin T; Porta C; Mosser AG; Giesing HA; Lomonossoff GP; Johnson JE
J Mol Recognit; 2000; 13(2):71-82. PubMed ID: 10822251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
